Initial digest — VEGFR2 receipt

what this node claims

Initial digest — VEGFR2

AlphaFold v6 prediction landed for **VEGFR2** (Vascular endothelial growth factor receptor 2). UniProt accession: `P35968`. Lane: `recovery`. Mean per-residue pLDDT: **71.14**. _(no notes)_

Open source surface

vertical proof spine

evidence / risk instrument

39%

thin proof

low debt pressure 29%

28%structuredebt

pLDDT pending

55%evidencethin

grade C

0%gatesdebt

0/5 gates

100%riskstrong

0 hard flags

22%exportdebt

no export

33%lineagedebt

incomplete spine

proof completeness

33% missing target, alphafold_metric, candidate, export

01 target
02 fold
03 alphafold metric
04 candidate
05 finding
06 export

Metrics and receipt inputs

confidence: 0.6
evidence refs: 1

AlphaFold metrics visual

Confident backbone model

71.1

1356 residues / min 24.44 / max 97.69 / source alphafold db

Very high 23.5% 318 residues / >=90

Confident 43.4% 589 residues / 70-89

Low 7.6% 103 residues / 50-69

Very low 25.5% 346 residues / <50

usable fold context with explicit model-confidence limits

Near-complete coverage / observed 1356 of 1356 residues.

residues 1240-1356 / mean 32.49
residues 1167-1236 / mean 32.26
residues 937-999 / mean 31.96
residues 785-822 / mean 39.87

proof debt register

Visible limits, not hidden cleanup.

29%

Peptide RX keeps unresolved proof debt attached to the public receipt. Some debts should be resolved; redaction and research-use boundaries should stay visible.

high low evidence grade attach graded finding with source-linked evidence

low computational-only status add independent evidence, challenge result, or witness review before strengthening

medium no candidate yet leave visible until a stronger public receipt resolves it

Initial digest — VEGFR2